AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Macsita-MXR 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Macsita-MXR 50/1000 Tablet

DiabetaComb 50/1000 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. DiabetaComb 50/1000 may be used as monotherapy or in conjunction with other antidiabetic drugs. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood glucose readings, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinue only under physician guidance. Continued adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices are integral to diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; learn how to identify and manage it. This medication isn't suitable for all individuals. Inform your physician of any prior kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or lactating individuals require medical consultation prior to use. Potential drug interactions exist; disclose all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor your renal function and blood sugar levels throughout treatment.

Uses of Macsita-MXR 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Macsita-MXR 50/1000 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Macsita-MXR 50/1000 Tablet whole; do not break, crush, or chew it. Administer this medication with food.

Common Side effects of Macsita-MXR 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Macsita-MXR 50/1000 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Macsita-MXR 50/1000 Tablets with food.

How Macsita-MXR 50/1000 Tablet works:

Macsita-MXR 50/1000 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Macsita-MXR 50/1000 Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Macsita-MXR 50/1000 tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Macsita-MXR 50/1000 tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Macsita-MXR 50/1000 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Macsita-MXR 50/1000 Tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Use of Macsita-MXR 50/1000 tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Seek medical counsel before using this medication.

What if you forget to take Macsita-MXR 50/1000 Tablet :

Should you forget a Macsita-MXR 50/1000 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Macsita-MXR 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Macsita-MXR 50/1000 Tablet

Macsita-MXR 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Macsita-MXR 50/1000 tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Macsita-MXR 50/1000 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Macsita-MXR 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 50/1000 tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Macsita-MXR 50/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Macsita-MXR 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Macsita-MXR 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Macsita-MXR 50/1000 Tablet is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol while taking Macsita-MXR 50/1000 tablets is unsafe and may raise the risk of lactic acidosis.
Macsita-MXR 50/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-MXR 50/1000 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep out of reach of children, pets, and others.
Macsita-MXR 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Macsita-MXR 50/1000 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Macsita-MXR 50/1000 Tablets are contraindicated in patients with known allergies to any constituent or excipient. Avoid use in patients with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Macsita-MXR 50/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-Associated Lactic Acidosis). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-MXR 50/1000 Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency can cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with potential cognitive changes. To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Macsita-MXR 50/1000 Table...
144